Translational Pharmacokinetic-Pharmacodynamic Modeling from Nonclinical to Clinical Development: A Case Study of Anticancer Drug, Crizotinib

Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 2

Abstract

The online version of this article (doi:10.1208/s12248-012-9436-4) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Shinji Yamazaki

Keywords

Related Articles

Stable Isotope Dilution Mass Spectrometry for Membrane Transporter Quantitation

This review provides an introduction to stable isotope dilution mass spectrometry (MS) and its emerging applications in the analysis of membrane transporter proteins. Various approaches and application examples, for the...

Bioequivalence studies for levothyroxine

The Food and Drug Administration (FDA) Guidance for Bioavailability and Bioequivalence Studies for Levothyroxine has been challenged by companies that manufacture brand-name products. Their contention is that the current...

Particle size analysis of concentrated phospholipid microemulsions: II. Photon correlation spectroscopy

The solvated droplet size of concentrated water-in-oil (w/o) microemulsions prepared frome egg and soy lecithin/water/isopropyl myristate and containing short-chain alcohol cosurfactants has been determined using photon...

Reaction Phenotyping: Current Industry Efforts to Identify Enzymes Responsible for Metabolizing Drug Candidates

Reaction phenotyping studies to identify specific enzymes involved in the metabolism of drug candidates are increasingly important in drug discovery efforts. Experimental approaches used for CYP reaction phenotyping incl...

Download PDF file
  • EP ID EP681110
  • DOI  10.1208/s12248-012-9436-4
  • Views 75
  • Downloads 0

How To Cite

Shinji Yamazaki (2013). Translational Pharmacokinetic-Pharmacodynamic Modeling from Nonclinical to Clinical Development: A Case Study of Anticancer Drug, Crizotinib. The AAPS Journal, 15(2), -. https://europub.co.uk./articles/-A-681110